Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | IMvigor130: atezolizumab +/- platinum-based chemo upfront for advanced urothelial carcinoma

Enrique Grande, MD, from the MD Anderson Cancer Center Madrid, Madrid, Spain, presents the results of IMvigor130 – testing atezolizumab as a single agent or combined with platinum-based chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma. Angela Lamarca, MD, PhD, from The Christie NHS Foundation Trust, Manchester, UK, then discusses these results.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.